Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Status:
Completed
Trial end date:
2021-03-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of brolucizumab vs.
aflibercept in the treatment of patients with visual impairment due to DME.